Video
An End-to-End Enabler of Biologic Innovation
Abstract: As the biopharma landscape grows more complex, Catalent works to ease the challenges of biologics development for its partners.
View Now
Presentation
Leveraging Gene Copy Number to Optimize Expression for Rapid, High-Titer Production of Complex Products in CHO Cells with GPEx® Lightening
Summary: Biotherapeutics are becoming increasingly sophisticated, often requiring the coordinated expression of multiple genes, processing enzymes, and cofactors.
View Now
Presentation
Precise Quantification of Criticial HCPs Using Customized MS Methods
Summary: This poster presents a customized mass spectrometry approach for sub-ppm quantitation of high-risk host cell proteins (HCPs) considered critical quality attributes.
View Now
Presentation
From Molecule to Formulation: A Systematic Approach to Assess Biologics Developability
Summary: This presentation introduces a systematic, data-driven approach for assessing the developability of biologic therapeutics, with a focus on pre-formulation development.
View Now
Webinars
Breaking Bottlenecks: Data-Driven Manufacturing and Case Management in Autologous Cell Therapy
Abstract: CAR-T therapies have proven their curative potential, but cell therapy developers continue to face challenges related to manufacturing complexities, costs, scalability, regulatory compliance, and supply chain management.
View Now
Offering Fact Sheet
Biologics Risk Reduction Through Early Phase Analytical Strategy
Summary: Catalent’s Bio Early Phase Success Package delivers an integrated analytical strategy designed to de-risk biologics development from discovery through IND.
View Now
Webinars
From Molecule to Formulation: A Systematic Approach to Assess Biologics Developability
Summary: This presentation introduces a systematic, data-driven approach for assessing the developability of biologic therapeutics, with a focus on pre-formulation development.
View Now
Offering Fact Sheet
Advanced iPSC Workflows: Accelerating Cell Therapy Development
Summary: Catalent’s advanced iPSC-based platforms offer GMP-ready solutions for gene editing and cell differentiation, enabling partners to streamline therapeutic development.
View Now
Webinars
Unlock the Potential of GPEx Lightning Accelerate Your HEK Cell Line Development
The cell line development technology platform revolutionizes the generation of complex biologics with unmatched speed, scalability, and flexibility.
View Now
White Papers
Manufacturing Strategies to Industrialize Autologous Therapies
Autologous cell therapies promise life-changing treatments but face steep barriers in scalability, cost, and reliability.
View Now
